Has Joseph Franklin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $53,943 in general payments to Joseph Franklin, MD across 113 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joseph Franklin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joseph Franklin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joseph Franklin, MD

Plastic Surgery · Cary, NCNPI 1730101213

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $46,000 of the $53,943 with a category attached, or 85.3%. Merz North America, Inc. accounts for 88.2% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $21,429, more than ten times the $1,616 reported in 2019. Among plastic surgery clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,943in general payments, 2019–2025

Across 113 payments — averaging $477.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merz North America, Inc.$48K
Biotissue Holdings Inc.$2K
Sientra, Inc.$940
Stryker$885
Medical Device Business Services, Inc.$870
AbbVie$486
plus $2K from 11 others

What the payments were for

Consulting fees$46,00085%
Travel & lodging$2,8305%
Food & beverage$5,1139%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merz North America, Inc.	33	$47,560
Biotissue Holdings Inc.	10	$1,582
Sientra, Inc.	12	$940
Stryker	10	$885
Medical Device Business Services, Inc.	6	$870
AbbVie(2 entities)	13	$486
Medtronic	8	$401
Integra Lifesciences Corporation	4	$266
Galderma Laboratories, L.p.	3	$202
Smith+Nephew	2	$179
Mentor Worldwide LLC	2	$170
Normatec Industries, LP	2	$156
Boston Scientific	2	$85
Motiva USA, LLC	1	$75
Musculoskeletal Transplant Foundation Inc.	1	$37
Revance Therapeutics, Inc.	1	$28
Aroa Biosurgery Incorporated	3	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$7,976
ARTOURA Breast Tissue Expander$774
MemoryGel Breast Implants$774
MemoryShape Breast Implants$774
SILTEX Breast Implants$774
EIKON$723
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$479
INTEGRA$364
PlasmaBlade$169
NATRELLE SALINE-FILLED BREAST IMPLANTS$147
OMNIGRAFT$132
PRIMATRIX$132
MEDIHONEY$132
TCC-EZ$132
AMNIOEXCEL$132
INTEGRA DERMAL REGENERATION TEMPLATE$121
BOTOX COSMETIC$121
GRAFIX PL$110
Stravix$110
MENTOR MemoryGel Resterilizable Gel Sizer$109

How this compares

$53,943 in reported general payments places this provider in the 90th percentile of 128 plastic surgery providers in North Carolina.

See all plastic surgery providers in North Carolina →

Medicare billing

Part B allowed, 2024

$15,835

Medicare patients

Services billed

173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	12	$109

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Cary

Rahman BarryCary$5K
Cindy WuCary$5K
Nicholas ClavinCharlotte$562K
Luther HoltonWilmington$533K
Theodore NyameCharlotte$364K
Bill KortesisWinston Salem$321K
Howard LevinsonDurham$167K
Suhail MithaniDurham$146K
Claire DillinghamGreensboro$142K
Cynthia DiehlRaleigh$87K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →